Characteristics of new users of recent antidiabetic drugs in Canada and the United Kingdom

Abstract Background Characteristics of patients using newer 2nd and 3rd line antidiabetic drugs in a real-world setting are poorly understood. We described the characteristics of new users of sodium-glucose co-transporter-2 inhibitors (SGLT-2i), dipeptidyl peptidase-4 inhibitors (DPP-4i), and glucag...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Vanessa C. Brunetti, Audray St-Jean, Sophie Dell’Aniello, Anat Fisher, Oriana H. Y. Yu, Shawn C. Bugden, Jean-Marc Daigle, Nianping Hu, Silvia Alessi-Severini, Baiju R. Shah, Paul E. Ronksley, Lisa M. Lix, Pierre Ernst, Kristian B. Filion, for the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2022-09-01
Serier:	BMC Endocrine Disorders
Fag:	Type 2 diabetes sodium-glucose co-transporter 2 inhibitors glucagon-like peptide 1 receptor agonists dipeptidyl peptidase 4 inhibitors
Online adgang:	https://doi.org/10.1186/s12902-022-01140-1
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!